Clinical Trial Update: Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gefitinib for locally advanced or metastatic thyroid cancer that did not respond to iodine therapy; the study has completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-31